Revlon kicks off new philanthropic platform with $1M donation
Dr. Dennis J. Slamon, Revlon global brand ambassador Halle Berry and Revlon CEO Lorenzo Delpani at the Revlon Love is On Luncheon Honoring Slamon in Los Angeles (Photo: Business Wire)
NEW YORK — Revlon has donated $1 million to the Revlon/UCLA Women’s Cancer Research Program, furthering its long-time commitment to eradicating women’s cancers.
The donation was unveiled on June 3 by Revlon chairman Ronald Perelman, CEO Lorenzo Delpani and global brand ambassador Halle Berry at a Lovee Is On event in Los Angeles. The luncheon honored Dr. Dennis J. Slamon, director of the Revlon/UCLA Women’s Cancer Research Program at UCLA’s Jonsson Comprehensive Cancer Center, for his achievements in cancer research.
The donation marks the first phase of Revlon’s new philanthropic platform of bigger and more impactful donations to women’s health initiatives, which is also part of Revlon’s Love is On global mission to inspire love.
“Love Is On is in everything we do at Revlon, including our commitment to caring for women’s health,” Delpani said. “It is love that inspired our philanthropic direction to make more significant and impactful donations to women’s health initiatives. We unveiled the first phase of this mission with a direct donation of $1 million to Dr. Dennis Slamon and the Revlon/UCLA Women’s Cancer Research Program. It is our goal that this donation will help to enable Dr. Slamon and his team to continue their research into major cancer breakthroughs that will lead to lives being saved, ultimately finding a cure.”
“We have made tremendous advancements in the field of breast cancer treatments over the past two decades, but our work is far from over,” Slamon added. “We are currently working on potential new therapies and treatments for triple-negative breast cancer and ovarian cancer, and this extremely generous donation will help us to continue this groundbreaking research that has the potential to save the lives of more women battling these deadly diseases.”
Since 1990, Perelman and Revlon, in collaboration with the Entertainment Industry Foundation and Lilly Tartikoff, have distributed $49 million to the Revlon/UCLA Women’s Cancer Research Program. These funds have helped accelerate research needed to bring cancer treatment drugs such as Herceptin and Ibrance to market.
Revlon will be unveiling a new campaign later this year to raise awareness and funds in support of other women’s health initiatives.
Former Mars executive joins Coty’s board
NEW YORK — Beauty brand Coty has added Paul Michaels, former global president of Mars to its board of directors.
“Paul S. Michaels is one of the most highly respected leaders in the consumer goods industry and we are excited to add him to Coty’s Board of Directors,” Bart Becht, chairman and interim CEO of Coty, said. “His expertise and creativity in working with global brands will be a tremendous asset to the company as we continue to pursue our strategy of returning Coty to profitable growth behind its brand building and efficiency programs.”
During his time at Mars, he led efforts to strengthen the company’s portfolio of businesses through brand revitalization and product innovation. He began his career at Procter & Gamble and later moved to Johnson & Johnson, where he spent 15 years building many of the company’s flagship brands. This included building and positioning as global leaders Johnson & Johnson’s health and beauty products such as Band-Aid Brand Adhesive Bandages, Reach toothbrushes and Johnson’s Baby Shampoo, among others.
“I have admired Coty for a number of years and I am looking forward to working with my fellow directors to help guide Coty to its next phase of growth,” Michaels said. “I have immense respect for Bart and his colleagues and feel that Coty is poised to enhance its leadership position in the global beauty industry.”
General Atlantic to acquire majority stake in Too Faced Cosmetics
IRVINE, Calif. and NEW YORK — Beauty brand Too Faced Cosmetics has announced that General Atlantic will acquire a majority stake in the company from Weston Presidio.
"We are so grateful to our loyal Too Faced customers who have fueled our growth from a small indie brand to a fixture within the beauty industry. To continue our growth trajectory, we were seeking a global thought leader experienced in partnering with founder-led, high growth companies, and the team at General Atlantic was a natural fit. Their experience will help us accelerate our expansion as we invite even more women around the world to 'own their pretty,’” stated Jeremy Johnson, co-founder and CEO of Too Faced.
Jerrod Blandino and Jeremy Johnson were both working behind cosmetics counters at major department stores when they created Too Faced in 1998.
"We always dreamed that Too Faced would grow into the global brand and industry leader that it is today. After 17 years, we feel blessed to still be passionate about what we do and have fun doing it," Jerrod Blandino, co-founder and chief creative officer, added. “We have so much admiration and respect for our "Too Faced Girl" and with General Atlantic's partnership, we're excited to continue making high quality makeup that she loves to wear.”
In conjunction with General Atlantic's investment, beauty industry veteran Ken Stevens will join as Too Faced's chairman, bringing a wealth of experience as former chairman of Ulta Beauty, former CEO of philosophy, and former president of Bath & Body Works. Andrew Crawford and Andrew Ferrer, both senior leaders on General Atlantic's Global Retail and Consumer sector team, will also join the board of directors.
The Too Faced founders and senior management team will retain significant ownership in the company.